Clinicalusedefinition-contraindication-example

R6 Ballot (1st Draft)

This page is part of the FHIR Specification v6.0.0-ballot1: Release 6 Ballot (1st Draft) (see Ballot Notes). The current version is 5.0.0. For a full list of available versions, see the Directory of published versions

Example ClinicalUseDefinition/example-contraindication (Narrative)

Biomedical Research and Regulation Work Group

Maturity Level: N/A

Standards Status: Informative

Compartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ClinicalUseDefinition.

Generated Narrative: ClinicalUseDefinition

Resource ClinicalUseDefinition "example-contraindication"

StructureDefinition Work Group: brr

type: contraindication

subject: MedicinalProductDefinition/example

contraindication
DiseaseSymptomProcedures
- Concept
* Concomitant treatment with any other anticoagulant agent ()
otherTherapy
relationshipType: Co-therapy(with) (therapyrelationshiptype#Co-therapy(with))
Treatments
- Concept
* Oralanticoagulants (medication#Oralanticoagulants)
otherTherapy
relationshipType: Co-therapy(with) (therapyrelationshiptype#Co-therapy(with))
Treatments
- Concept
* Lowmolecularweightheparins (medication#Lowmolecularweightheparins)

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.